Series B funding from MedVenture Partners and DBJ Capital
- Author: admin_epmed
- Category: NEWS
We have raised Series B funding from MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., and DBJ Capital Co., Ltd.
We will continue to develop intravascular EEG measurement devices.
Related posts
E.P. Medical website launched
In November 2021, the E.P. Medical website was launched.
- Category: NEWS
A specific clinical study at the University of Tsukuba has been published on jRCT
Following deliberation by the Clinical Research Review Committee of the University of Tsukuba, information on specific clinical research on our…
- Category: NEWS
Investment in E.P. Medical Inc.
MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., has underwritten a Series A1 investment in E.P.…
- Category: NEWS
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our Endovascular EEG device (EP-01).
We are pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our…
- Category: NEWS